openPR Logo
Press release

Bispecific Antibody Market Global Analysis, Covid-19 Impact, Long-Term Investment with Top Most Key Players are Abbvie, Celgene, Amgen Inc., Bayer AG, Novartis AG, Merck & Co., Inc. By 2027

Bispecific Antibody Market

Bispecific Antibody Market

Global Bispecific Antibody Market is valued at USD 489.7 Million in 2020 and expected to reach USD 810.4 Million by 2027 with the CAGR of 6.5% over the forecast period.

Global Bispecific Antibody Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing numbers of patients associated with infectious diseases and cancers as well as growing numbers of Covid-19 patients are contributing in the market growth.

Scope of Global Bispecific Antibody Market Report

Bispecific antibody is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Most of the bispecific antibodies are being developed for the treatment of multiple cancers followed by infectious disease, CNS disorders, inflammatory and autoimmune disorders.

You Can Download 200 Pages PDF Copy of Bispecific Antibody Market @ https://brandessenceresearch.com/requestSample/PostId/1129?utm_source=OpenPR&utm_medium=AR

The benefits of bispecific antibodies over monoclonal therapeutics are due to their higher binding avidity to targets, which can interact with more than one surface antigen and boosted cytotoxic effects. It is because of the direct recruitment of effector cells to the site of the disease or in tumorigenic conditions. Bispecific antibodies may be used to improve clinical efficacy by targeting two disease mechanisms for the treatment of complex human diseases in a single agent.

Bispecific antibodies also hold promise for certain therapeutic applications difficult to achieve by single-targeting monospecific antibodies, such as immune cell retargeting, site-specific targeting, enabling therapeutics to cross the blood–brain barrier, and unique receptor modulation.

Bispecific antibodies (bsAbs) combine the specificities of two antibodies to target separate antigens or epitopes at the same time. BsAbs with 'two target' functionality can bind to several receptors or ligands on the surface of cells.

Top Companies:

Key Players for Global Bispecific Antibody Market Report– Oncomed Pharmaceuticals, Abbvie, Bayer AG, Janseen Biotech, Fabion Pharmaceuticals, Novartis AG, Pfizer Inc., ImmunGene, Inc., Celgene, Amgen Inc., Immunocore Limited, Merck & Co., Inc., Paktis Antibody Services GmBH, Ganymed Pharmaceuticals, Dow Pharmaceutical Solutions, and F. Hoffmann-La Roche AG others.

Key Benefits for Global Bispecific Antibody Market Report–
• Global Bispecific Antibody Market report covers in depth historical and forecast analysis.
• Global Bispecific Antibody Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Bispecific Antibody Market report helps to identify opportunities in market place.
• Global Bispecific Antibody Market report covers extensive analysis of emerging trends and competitive landscape.

Segmentation Analysis:

Global Bispecific Antibody Market is segmented on the basis of product types, applications, and region & country level. Based upon product type, bispecific antibody market is classified into blinatumab, catumaxomab and duligotumab.

Global Bispecific Antibody Market Segmentation

By Product Type:

• Blinatumab
• Catumaxomab
• Duligotumab

By Application:

• Infectious Diseases
• Viral Infections
• Cancer Diagnostics
• Gene Therapy
• Signaling Pathways
• Bacterial Infections
• Tumor Angiogenesis
• Others

Increasing Numbers of Patients Associated with Infectious Diseases and Cancers as Well as Growing Numbers of Covid-19 Patients are the Major Factors Driving the Market Growth.

The growing demand for bispecific antibodies for the treatment of infectious diseases, cancer tumors, bacterial infections, and cancer diagnostics is one of the major factors fostering the growth of bispecific antibody market.

Since the numbers of cancer patients and infectious diseases are growing, the requirement to cure the patients has increased. For instance, according to the Journal of Hematology & Oncology, several bispecific antibody cytokines have been identified as important mediators in the development of inflammatory and autoimmune disorders.

Request for Methodology of this report: https://brandessenceresearch.com/requestMethodology/PostId/1129?utm_source=OpenPR&utm_medium=AR

Report Highlights:
• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation opportunities and disruptive technologies, company overview, revenue shares, strategic overview of Market supply and demand
• Statistical data in terms of value (US$) as well as Volume (units) till 2027
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• The data analysis present in the report is based on the combination of both historical as well as current growth parameters resources
• Recommendations to companies for
strengthening their foothold in the market
Market Dynamics of Bispecific Antibody Markets

Global Bispecific Antibody market report has the best research offerings and the required critical information for looking new product trends or competitive analysis of an existing or emerging market. Companies can sharpen their competitive edge again and again with this business report.

The report comprises of expert insights on global industries, products, company profiles, and market trends. Users can gain unlimited, company-wide access to a comprehensive catalog of industry-specific market research from this industry analysis report. The market report examines industries at a much higher level than an industry study.

Table of Content: Global Bispecific Antibody Market Research Report

Chapter 1: Global Bispecific Antibody Industry Overview
Chapter 2: Global Economic Impact on Bispecific Antibody Markets
Chapter 3: Global Market Size Competition by Industry Producers
Chapter 4: Global Productions, Revenue (Value), according to Regions
Chapter 5: Global Supplies (Production), Consumption, Export, Import, geographically
Chapter 6: Global Productions, Revenue (Value), Price Trend, Product Type
Chapter 7: Global Market Analysis, on the basis of Application
Chapter 8: Bispecific Antibody Market Industry Value Chain
Chapter 9: Bispecific Antibody Market Chain, Sourcing Strategy, and Downstream Buyers
Chapter 10: Strategies and key policies by Distributors/Suppliers/Traders
Chapter 11: Key Economic Indicators, by Market Vendors
Chapter 12: Market Effect Factors Analysis
Chapter 13: Global Bispecific Antibody Market Forecast Period
Chapter 14: Future of the Market
Chapter 15: Appendix
Global Bispecific Antibody Markets: Regional Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2021 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
• South America (Brazil etc.)
• Middle East and Africa (Egypt and GCC Countries)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Trending Link:

https://www.prnewswire.com/news-releases/at-cagr-of-6-71--healthcare-consulting-industry-expected-to-cross-20-usd-billion-by-2025-says-brandessence-market-research-301200108.html

https://www.prnewswire.com/news-releases/at-6-15-cagr--global-construction-glass-market-is-expected-to-reach-usd-66-83-billion-in-2026--says-brandessence-market-research-301201873.html

https://www.prnewswire.com/news-releases/at-cagr-of-12-22-remote-patient-monitoring-market-size-is-expected-to-reach-usd-2936-38-million-by-2025-says-brandessence-market-research-301206158.html

https://www.prnewswire.com/news-releases/robotic-process-automation-rpa-industry-projected-to-reach-18339-95-million-in-2027--says-brandessence-market-research-301209978.html

Contact Us:

Alan Ruffalo
Corporate Sales: +44-20380741
Email: sales@brandessenceresearch.com
Web: https://brandessenceresearch.com/

About: Brandessence Market Research Inc.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bispecific Antibody Market Global Analysis, Covid-19 Impact, Long-Term Investment with Top Most Key Players are Abbvie, Celgene, Amgen Inc., Bayer AG, Novartis AG, Merck & Co., Inc. By 2027 here

News-ID: 2300672 • Views:

More Releases from Brandessence Market Research & Consulting Pvt ltd.

Neuroscience Antibodies and Assays Market Scenario, Gross Margin, Future Trends, …
Market Overview: Global Neuroscience Antibodies and Assays Market to reach USD 5.1 billion by 2025 Global Neuroscience Antibodies and Assays Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience
Atomic Layer Deposition (ALD) Market Revenue, Top Players, Impact Analysis, Upco …
Market Overview: Global Atomic Layer Deposition (ALD) Market to reach USD 3.1 billion by 2025 Global Atomic Layer Deposition (ALD) Market valued approximately USD 1.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 12.04% over the forecast period 2017-2025. Increasing need for miniaturized components and Nano-technology, advancement in electronic sectors, increasing concern for global warming and emergence of new technologies like dye-sensitized solar cells, are
Diabetic Neuropathy Market Share, Company Profiles, Future Demand, Opportunities …
Market Overview: Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.80% over the forecast period 2017-2025. The growth of this market primarily driven by the ever-growing pool of geriatric population with diabetes. The rise in availability of suitable treatment options and the growing awareness on PDN
Circulating Tumor Cells (CTC) Market Global Trends, COVID-19 Impact Analysis, Co …
Market Overview: Global Circulating Tumor Cells (CTC) Market to reach USD 22.5 billion by 2025 Global Circulating Tumor Cells (CTC) Market valued approximately USD 5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 18.20% over the forecast period 2017-2025. Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various

All 5 Releases


More Releases for Bispecific

Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Bispecific Drug Innovation - Creative Biolabs Concludes Its Journey at the 15th …
On September 5, Creative Biolabs successfully concluded its participation in the 15th Annual World Bispecific Summit. New York, USA - September 10, 2024 - The summit brought together leading experts in the bispecific antibody [https://www.creative-biolabs.com/bsab/bispecific-antibody-bsab-development-service.htm] (BsAb) field from around the globe, offering attendees a rich platform to discuss cutting-edge developments and future directions. Image: https://www.getnews.info/uploads/b7ea13d648fcb7917ba9b55571b2ba35.png In recent years, this field has grown rapidly, becoming a focal point in biopharmaceutical research and development. A
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes. One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in
Global Bispecific Antibody Market Research Report Forecast 2017 to 2021Global Bi …
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Bispecific Antibody Market Research Report Forecast 2017 to 2021 "with detailed Analysis, Forecast and Strategies. The Global Bispecific Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bispecific Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies